Intra-Cellular Therapies, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Intra-Cellular Therapies, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2019 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending June 30, 2024 was $4.57M, a 15.1% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.57M +$599K +15.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.02M +$48K +1.21% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.97M Dec 31, 2023 10-K 2024-02-22
Q3 2023 $3.97M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $3.97M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $3.97M Mar 31, 2023 10-Q 2023-05-04
Q4 2019 $3.49M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $3.45M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.45M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.45M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.